IL1B and periodontitis: Speculatively, anti-IL-1 treatments could be used for the control of periodontitis in for example CyN and such interventions could also interrupt the periodic granulopoiesis dysfunction in CyN if that is at least partly driven by cytokine effects on hematopoiesis in bone marrow.